Skip to content
healthcare.dev

DAPAGLIFLOZIN

NDC 62332-393, DAPAGLIFLOZIN, tablet, film coated, from Alembic Pharmaceuticals Inc..

Product NDC
62332-393
Status
Listed
Labeler
Alembic Pharmaceuticals Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211560
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62332-393 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DAPAGLIFLOZIN10 mg/1

Pharmacologic classes

Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]

Package NDCNDC-11Package
62332-393-306233203933030 TABLET, FILM COATED in 1 BOTTLE (62332-393-30)
62332-393-906233203939090 TABLET, FILM COATED in 1 BOTTLE (62332-393-90)
62332-393-91623320393911000 TABLET, FILM COATED in 1 BOTTLE (62332-393-91)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/840e2146-2383-489b-bcc4-fecfe986685a
  • NADAC price for package 62332039330

    GET /v1/drugs/nadac/62332039330

Use it

Look up 62332-393 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62332-393 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62332-393. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.